BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8297722)

  • 41. Polyclonal anti-idiotypic antibodies mimicking the small cell lung carcinoma antigen cluster-5A interact with a panel of antibodies and induce specific immune response in animals.
    Zwicky C; Stahel RA; Jaksche H; Waibel R; Lehmann HP; Loibner H
    Br J Cancer Suppl; 1991 Jun; 14():67-70. PubMed ID: 1645576
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunoscintigraphy of small-cell lung cancer xenografts with anti neural cell adhesion molecule monoclonal antibody, 123C3: improvement of tumour uptake by internalisation.
    Kwa HB; Wesseling J; Verhoeven AH; van Zandwijk N; Hilkens J
    Br J Cancer; 1996 Feb; 73(4):439-46. PubMed ID: 8595157
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Two-step targeting and dosimetry for small cell lung cancer xenograft with anti-NCAM/antihistamine bispecific antibody and radioiodinated bivalent hapten.
    Hosono M; Hosono MN; Kraeber-Bodéré F; Devys A; Thédrez P; Faivre-Chauvet A; Gautherot E; Barbet J; Chatal JF
    J Nucl Med; 1999 Jul; 40(7):1216-21. PubMed ID: 10405144
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Discrimination of human small cell and non-small cell lung tumors by a panel of monoclonal antibodies.
    Tong AW; Lee JC; Stone MJ
    J Natl Cancer Inst; 1986 Nov; 77(5):1023-33. PubMed ID: 3022055
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunolocalisation and imaging of small cell cancer xenografts by the IgG2a monoclonal antibody SWA11.
    Smith A; Waibel R; Westera G; Martin A; Zimmerman AT; Stahel RA
    Br J Cancer; 1989 Feb; 59(2):174-8. PubMed ID: 2539173
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of epithelial and neural antigens in small cell and non small cell lung carcinoma.
    Moss F; Bobrow LG; Sheppard MN; Griffiths M; Rowe D; Beverley PC; Addis B; Souhami RL
    J Pathol; 1986 Jun; 149(2):103-11. PubMed ID: 2426429
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neuroectodermal tumors of the peripheral and the central nervous system share neuroendocrine N-CAM-related antigens with small cell lung carcinomas.
    Molenaar WM; de Leij L; Trojanowski JQ
    Acta Neuropathol; 1991; 83(1):46-54. PubMed ID: 1665274
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A novel monoclonal antibody-defined antigen which distinguishes human non-small cell from small cell lung carcinomas.
    Sobol RE; Peters RE; Astarita RW; Hofeditz C; Masui H; Burton D; Handley HH; Glassy MC; Fairshter R; Carlo DJ
    Cancer Res; 1986 Sep; 46(9):4746-50. PubMed ID: 3015395
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Penetration and binding of radiolabeled anti-carcinoembryonic antigen monoclonal antibodies and their antigen binding fragments in human colon multicellular tumor spheroids.
    Sutherland R; Buchegger F; Schreyer M; Vacca A; Mach JP
    Cancer Res; 1987 Mar; 47(6):1627-33. PubMed ID: 3545451
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The expression of small cell lung cancer related antigens in foetal lung and kidney.
    Bobrow LG; Happerfield L; Patel K
    Br J Cancer Suppl; 1991 Jun; 14():56-8. PubMed ID: 2039712
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Induction of intercellular adhesion molecule 1 on small cell lung carcinoma cell lines by gamma-interferon enhances spontaneous and bispecific anti-CD3 x antitumor antibody-directed lymphokine activated killer cell cytotoxicity.
    Azuma A; Yagita H; Matsuda H; Okumura K; Niitani H
    Cancer Res; 1992 Sep; 52(18):4890-4. PubMed ID: 1381273
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Modulation of neuroendocrine surface antigens in oncogene-activated small cell lung cancer lines.
    Doyle LA; Mabry M; Stahel RA; Waibel R; Goldstein LH
    Br J Cancer Suppl; 1991 Jun; 14():39-42. PubMed ID: 1645569
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of interferon gamma (IFN gamma) and tumor necrosis factor alpha (TNF alpha) association in intraperitoneal radioimmunotherapy: studies on an in vitro micrometastasis model.
    Imbert-Marcille BM; Berreur M; Thedrez P; Riet A; Devys A; Chatal JF; Pradal G
    Anticancer Drug Des; 1995 Sep; 10(6):491-505. PubMed ID: 7575990
    [TBL] [Abstract][Full Text] [Related]  

  • 54. NY-ESO-1 may be a potential target for lung cancer immunotherapy.
    Lee L; Wang RF; Wang X; Mixon A; Johnson BE; Rosenberg SA; Schrump DS
    Cancer J Sci Am; 1999; 5(1):20-5. PubMed ID: 10188057
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Frequency of SOX Group B (SOX1, 2, 3) and ZIC2 antibodies in Turkish patients with small cell lung carcinoma and their correlation with clinical parameters.
    Vural B; Chen LC; Saip P; Chen YT; Ustuner Z; Gonen M; Simpson AJ; Old LJ; Ozbek U; Gure AO
    Cancer; 2005 Jun; 103(12):2575-83. PubMed ID: 15880380
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Selective immunotherapy of small cell cancer xenografts using 131I-labelled SWA11 antibody.
    Smith A; Waibel R; Stahel RA
    Br J Cancer; 1991 Aug; 64(2):263-6. PubMed ID: 1654073
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular and biological properties of an abrin A chain immunotoxin designed for therapy of human small cell lung cancer.
    Wawrzynczak EJ; Zangemeister-Wittke U; Waibel R; Henry RV; Parnell GD; Cumber AJ; Jones M; Stahel RA
    Br J Cancer; 1992 Aug; 66(2):361-6. PubMed ID: 1323991
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Uptake kinetics of monoclonal antibodies by human malignant melanoma multicell spheroids.
    Kwok CS; Cole SE; Liao SK
    Cancer Res; 1988 Apr; 48(7):1856-63. PubMed ID: 3349464
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Internalization of monoclonal antibodies selected for immunotoxin activity against small-cell lung cancer.
    Weltman JK; Melucci CL; Chen J; Davidson AE
    Hybridoma; 1992 Oct; 11(5):547-59. PubMed ID: 1334041
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Monoclonal antibodies recognising the cluster 2 antigen associated with human small cell lung cancer mediate the toxic effects of ricin A chain in an indirect assay of immunotoxin cytotoxicity.
    Derbyshire EJ; Wawrzynczak EJ
    Br J Cancer Suppl; 1991 Jun; 14():74-7. PubMed ID: 1645578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.